Maehara Yukari, Fujibayashi Kazutoshi, Kuwatsuru Ryohei, Daida Hiroyuki, Aoki Shigeki
Juntendo Iji Zasshi. 2024 Dec 31;70(6):445-452. doi: 10.14789/ejmj.JMJ24-0015-OA. eCollection 2024.
After the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) outbreak, a state of emergency was imposed to stop the spread of infection, resulting in restrictions on routine medical examinations. As a result, there has been a decline in cancer screening and detection. However, it is uncertain how many more cancer cases among routine outpatients have been detected recently.
We retrospectively identified regular outpatients with no history of cancer treatment at the Juntendo University Hospital. The difference in the percentage of these patients who initiated cancer treatment within the following year, before and after the SARS-CoV-2 pandemic was analyzed.
A total of 33,417, 32,579, and 30,303 regular outpatients with no history of cancer treatment were identified for fiscal years 2018, 2019, and 2020, respectively. The percentage of these patients with new cancer treatment within the following fiscal year was 454 (1.36%) for 2018, 440 (1.35%) for 2019, and 416 (1.37%) for 2021. There was no statistically significant difference in the percentage of patients initiating cancer treatments before and after the SARS-CoV-2 pandemic (2018 vs. 2020, 2019 vs. 2020, respectively P = 0.88, 0.81) among patients who regularly visited outpatients at our hospital.
The SARS-CoV-2 pandemic had no effect on the percentage of regular outpatients newly treated for cancer.
在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）爆发后，日本实施了紧急状态以阻止感染传播，这导致常规医学检查受到限制。结果，癌症筛查和检测数量有所下降。然而，目前尚不确定近期在常规门诊患者中又检测出了多少新增癌症病例。
我们回顾性地确定了顺天堂大学医院中无癌症治疗史的定期门诊患者。分析了这些患者在SARS-CoV-2大流行之前和之后次年开始接受癌症治疗的百分比差异。
分别在2018财年、2019财年和2020财年确定了33417例、32579例和30303例无癌症治疗史的定期门诊患者。这些患者在下一财年内接受新癌症治疗的百分比在2018年为454例（1.36%），2019年为440例（1.35%），2021年为416例（1.37%）。在我院定期就诊的患者中，SARS-CoV-2大流行前后开始接受癌症治疗的患者百分比无统计学显著差异（分别为2018年与2020年、2019年与2020年，P = 0.88，0.81）。
SARS-CoV-2大流行对新接受癌症治疗的定期门诊患者百分比没有影响。
